Back to Search
KIM HOUSE, MD
MD
Geriatric Medicine (Internal Medicine) Physician
NPI: 1699733550Individual
Specialties, Licenses & Credentials
Geriatric Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Geriatric Medicine
Code: 207RG0300X
49491(GA)
Research & Publications (20)
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products.
PMID 19302910·Clin Ther·2009
4-observational
Corrosion of orthodontic appliances--should we care?
PMID 18405823·Am J Orthod Dentofacial Orthop·2008
6-review
Optimizing the use of 17P in pregnant managed Medicaid members.
PMID 18274315·Manag Care·2008
4-observational
Electrochemical acceleration of chemical weathering as an energetically feasible approach to mitigating anthropogenic climate change.
PMID 18200880·Environ Sci Technol·2007
8-other
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
PMID 17825690·Clin Ther·2007
4-observational
Permanent carbon dioxide storage in deep-sea sediments.
PMID 16894174·Proc Natl Acad Sci U S A·2006
7-preclinical
An in-vitro investigation into the use of a single component self-etching primer adhesive system for orthodontic bonding: a pilot study.
PMID 16751433·J Orthod·2006
4-observational
An investigation into the use of a single component self-etching primer adhesive system for orthodontic bonding: a randomized controlled clinical trial.
PMID 16514132·J Orthod·2006
4-observational
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
PMID 16490581·Clin Ther·2006
2-rct
17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days.
PMID 16277194·Manag Care·2005
8-other
The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
PMID 16095144·Ann Allergy Asthma Immunol·2005
3-trial
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
PMID 15641629·J Asthma·2004
3-trial
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
PMID 15521371·Ann Allergy Asthma Immunol·2004
3-trial
A paralleling device and ethylene vinyl acetate baffles for use with mandibular distraction osteogenesis: technical note.
PMID 15489362·J Orthod·2004
5-case
Measuring parent attributes and supervision behaviors relevant to child injury risk: examining the usefulness of questionnaire measures.
PMID 15066978·Inj Prev·2004
8-other
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
PMID 11101186·Ann Allergy Asthma Immunol·2000
3-trial
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
PMID 10856143·J Allergy Clin Immunol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1670 CLAIRMONT RD.
DECATUR, GA 30033 - Phone
- (404) 321-6111
Quick Facts
- NPI
- 1699733550
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile